First Quadrant’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-19,500
| Closed | -$215K | – | 874 |
|
|
2016
Q1 | $215K | Sell |
19,500
-6,400
| -25% | -$70.6K | ﹤0.01% | 566 |
|
|
2015
Q4 | $238K | Sell |
25,900
-65,800
| -72% | -$605K | 0.01% | 543 |
|
|
2015
Q3 | $636K | Buy |
91,700
+28,200
| +44% | +$196K | 0.01% | 429 |
|
|
2015
Q2 | $624K | Buy |
63,500
+33,700
| +113% | +$331K | 0.01% | 442 |
|
|
2015
Q1 | $264K | Buy |
29,800
+25,300
| +562% | +$224K | 0.01% | 508 |
|
|
2014
Q4 | $39K | Sell |
4,500
-37,000
| -89% | -$321K | ﹤0.01% | 674 |
|
|
2014
Q3 | $286K | Hold |
41,500
| – | – | 0.01% | 509 |
|
|
2014
Q2 | $218K | Sell |
41,500
-23,200
| -36% | -$122K | ﹤0.01% | 565 |
|
|
2014
Q1 | $294K | Hold |
64,700
| – | – | 0.01% | 496 |
|
|
2013
Q4 | $326K | Sell |
64,700
-35,300
| -35% | -$178K | 0.01% | 505 |
|
|
2013
Q3 | $507K | Sell |
100,000
-28,100
| -22% | -$142K | 0.01% | 456 |
|
|
2013
Q2 | $635K | Buy |
+128,100
| New | +$635K | 0.02% | 410 |
|